AxoGen AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries. | ![]() BioPerfectus BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables. | |
Founding Date | Founding Date 2002 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Alachua, US HQ Burleson, US | Locations Taizhou, CN HQ Shanghai, CN Belfast, GB Natick, US |
Employees | Employees 37133% increase | Employees 592 |
Valuation ($) | Valuation ($) 611.9 m | Valuation ($) 616.7 m |
Financial | ||
Revenue (est.) | Revenue (est.) $225.2m (FY, 2025) | Revenue (est.) ¥324.6m (FY, 2024) |
Cost of goods | Cost of goods $57.9m (FY, 2025) | Cost of goods ¥132m (FY, 2024) |
Gross profit | Gross profit $167.4m (FY, 2025) | Gross profit ¥210.9m (FY, 2024) |
Net income | Net income ($15.7m) (FY, 2025) | Net income (¥2m) (FY, 2024) |

BioPerfectus (also known as Jiangsu Bioperfectus Technologies, 江苏硕世生物科技股份有限公司) is a company focused on nucleic acid extraction systems, PCR-based assays, and related consumables.
View company